MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Anavex Life Sciences Corp. Company Profile (NASDAQ:AVXL)

Consensus Ratings for Anavex Life Sciences Corp. (NASDAQ:AVXL) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.50 (112.22% upside)

Analysts' Ratings History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016Maxim GroupReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2016FBR & CoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/15/2016        
5/11/2016Q2($0.16)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/8/2016Q116($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
12/29/2015Q4($0.06)($0.65)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Anavex Life Sciences Corp. (NASDAQ:AVXL)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.14)($0.14)($0.14)
Q2 20161($0.14)($0.14)($0.14)
Q3 20161($0.09)($0.09)($0.09)
Q4 20161($0.08)($0.08)($0.08)
(Data provided by Zacks Investment Research)
Dividend History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/14/2015Christopher U MisslingCEOBuy1,000$0.52$520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2015Christopher U MisslingCEOBuy1,000$0.53$530.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2015Christopher U MisslingCEOBuy2,000$0.49$980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Christopher U MisslingCEOBuy2,000$0.45$900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2015Christopher U MisslingCEOBuy1,000$0.47$470.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015Christopher U MisslingCEOBuy1,000$0.42$420.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Christopher U MisslingCEOBuy1,000$0.44$440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Christopher U MisslingCEOBuy1,000$0.43$430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Christopher U MisslingCEOBuy1,000$0.36$360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Christopher U MisslingCEOBuy1,000$0.35$350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Christopher U MisslingCEOBuy1,000$0.37$370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Anavex Life Sciences Corp. (NASDAQ:AVXL)
DateHeadline
07/01/16 02:44 PMA Major Breakout On Anavex Life Sciences Corp (NASDAQ:AVXL) - Insider Financial
07/01/16 07:25 AMAnavex Life Sciences (AVXL) in Focus: Stock Rises 16.4% -
06/30/16 02:51 PMUpdate on Stock Volatility for: Anavex Life Sciences Corp. (:AVXL) - Engelwood Daily
06/30/16 02:51 PMStock Moving Higher in Session: Anavex Life Sciences Corp. (:AVXL) - Telanagana Press
06/29/16 02:41 PMWatching Stock Volatility for: Anavex Life Sciences Corp. (:AVXL) - Engelwood Daily
06/29/16 10:53 AMStocks in Focus: Avangrid, Inc. (NYSE:AGR), Anavex Life Sciences Corp. (NASDAQ:AVXL), Realty Income Corporation ... - KC Register
06/27/16 05:05 PM3 Reasons Anavex Stock Could Rise -
06/27/16 07:24 AMMost Volatile Biotech Stocks- Immunomedics Inc. (NASDAQ:IMMU), Anavex Life Sciences Corp. (NASDAQ:AVXL) - Seneca Globe
06/25/16 02:40 PMStocks within Analysts Spotlight: Anavex Life Sciences Corp (NASDAQ:AVXL) , Titan Pharmaceuticals, Inc. (NASDAQ ... - Street Updates
06/25/16 07:18 AMAnavex Life Sciences (NASDAQ:AVXL) to present preclinical data for ANAVEX 2-73: Viacom, (NASDAQ:VIAB), Emerge ... - KC Register
06/25/16 07:18 AMShare Volatility Check for: Anavex Life Sciences Corp. (:AVXL) - Press Telegraph
06/24/16 07:44 AMAnavex Life Sciences (AVXL) Announces Presentation at Rett Syndrome Symposium
06/23/16 10:06 PMMaxim Weighs In on Anavex Life Sciences Corp. (AVXL) and Pluristem Therapeutics Inc. (PSTI) Following Orphan ... - Smarter Analyst
06/23/16 10:06 PMAnavex Life Sciences (AVXL) Announces Presentation at Rett Syndrome Symposium - StreetInsider.com
06/23/16 04:10 PMAnavex to Present at the 2016 Rett Syndrome Symposium
06/23/16 10:28 AMAnavex Life Sciences' (AVXL) ANAVEX 2-73 Granted FDA Orphan Drug Designation as IS Treatment
06/22/16 07:48 PMMaxim Weighs In on Anavex Life Sciences Corp. (AVXL), Pluristem Therapeutics Inc. (PSTI) Following Orphan ... - Smarter Analyst
06/22/16 02:40 PMAnavex Life Sciences Corp. (NasdaqCM:AVXL) Stock Momentum Hits EXTREME Weakness - CML News
06/22/16 07:26 AMAnavex Life Sciences' (AVXL) ANAVEX 2-73 Granted FDA Orphan Drug Designation as IS Treatment - StreetInsider.com
06/22/16 06:43 AMAnavex Gets FDA Orphan Drug Status For ANAVEX 2-73 For Infantile Spasms Treatment -
06/20/16 02:41 PMTrending Tickers: ViewRay, Inc. (NASDAQ:VRAY), Anavex Life Sciences Corp. (NASDAQ:AVXL), Ophthotech ... - KC Register
06/11/16 10:50 AMCoverage of Biotechnology Equities - Pacific Biosciences of California, Peregrine Pharma, Dynavax Technologies and Anavex Life Sciences
06/09/16 02:40 PMBetter Buy: Anavex Life Sciences Corp. vs. Biogen - Motley Fool
06/09/16 01:21 PMBetter Buy: Anavex Life Sciences Corp. vs. Biogen -
06/06/16 01:30 PMAnavex Life Sciences Corp. :AVXL-US: Earnings Analysis: Q2, 2016 By the Numbers : June 6, 2016 -
06/06/16 11:22 AMAnavex Life Sciences (AVXL) Presents Positive ANAVEX 2-73 Data in Fragile X at ASCO - StreetInsider.com
06/06/16 07:48 AMMarket Has Not Yet Noticed Potential in Anavex Life Sciences (AVXL); Have You? -
06/06/16 06:59 AMAnavex Reveals Positive Preclinical Results With ANAVEX 2-73 In Fragile X -
06/04/16 11:11 AMAnalyst's Noticeable Buzzers: PerkinElmer, Inc. (NYSE:PKI) , Anavex Life Sciences Corp. (NASDAQ:AVXL) - Street Updates
05/24/16 01:27 PMBull Vs. Bear: Anavex Life Sciences Corp. - Motley Fool - Motley FoolBull Vs. Bear: Anavex Life Sciences Corp.Motley FoolAnavex Life Sciences (NASDAQ:AVXL) a small-cap clinical-stage biotech with an eye on Alzheimer's, has been on a great run over the past year, although fairly volatile since uplisting from the Pink Sheets to the Nasdaq exchange last October. Despite the ...and more »
05/23/16 03:56 PMBull Vs. Bear: Anavex Life Sciences Corp. - Here's the case for, and against, buying Anavex Life Sciences' stock.
05/23/16 01:43 PMStock Runners: Anavex Life Sciences Corp. (NASDAQ:AVXL), Galapagos NV (NASDAQ:GLPG), PCM, Inc. (NASDAQ ... - KC Register - Stock Runners: Anavex Life Sciences Corp. (NASDAQ:AVXL), Galapagos NV (NASDAQ:GLPG), PCM, Inc. (NASDAQ ...KC RegisterAnavex Life Sciences Corp. (NASDAQ:AVXL) reports the U.S. Food and Drug Administration's (FDA) Office of Orphan Product Development (OOPD) has granted Orphan Drug Designation (ODD) to ANAVEX 2-73 for the treatment of Rett syndrome. The FDA's ...
05/20/16 01:57 PMStocks in Volatile Measures: Anavex Life Sciences (NASDAQ:AVXL), CBRE Group (NYSE:CBG), HP Inc. (NYSE:HPQ) - Street Wise Report (press release) (blog) - Stocks in Volatile Measures: Anavex Life Sciences (NASDAQ:AVXL), CBRE Group (NYSE:CBG), HP Inc. (NYSE:HPQ)Street Wise Report (press release) (blog)Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) [Trend Analysis] swings enthusiastically in regular trading session, it a gain of 0.99% to close at $4.09. Anavex Life Sciences Corp. (AVXL) announced that treatment with ANAVEX 2-73 significantly ...Active Stocks According With Bulls And Bears- Anavex Life Sciences (AVXL), American Eagle Outfitters (AEO), Petroleo ...Seneca Globeall 6 news articles »
05/20/16 07:59 AMAnavex Gets Orphan Drug Status From FDA For ANAVEX 2-73 For Rett Syndrome Treatment -
05/20/16 06:00 AMAnavex Announces U.S. FDA Orphan Drug Designation to ANAVEX 2-73 for the Treatment of Rett Syndrome - [GlobeNewswire] - NEW YORK, May 20, 2016-- Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases ...
05/19/16 12:04 PMANAVEX LIFE SCIENCES CORP. Financials -
05/18/16 01:46 PMAnavex Life Sciences (AVXL) Announces Significant Preclinical ANAVEX 2-73 Data in Infantile Spasms - StreetInsider.com - Anavex Life Sciences (AVXL) Announces Significant Preclinical ANAVEX 2-73 Data in Infantile SpasmsStreetInsider.comAnavex Life Sciences Corp. (Nasdaq: AVXL) announces that treatment with ANAVEX 2-73 significantly reduced the number of spasms in an animal model with infantile spasms (epileptic spasms) in infant rats. In the preclinical study, following prenatal ...Anavex Life Sciences Reports Positive Preclinical Data for ANAVEX 2-73; Shares Rise 2% in Pre Market (OTCMKTS ...Sonoran Weekly Reviewall 2 news articles »
05/18/16 06:00 AMAnavex Announces Positive Preclinical Data for ANAVEX 2-73 in Infantile Spasms - [GlobeNewswire] - NEW YORK, May 18, 2016-- Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases ...
05/14/16 01:11 PMWorst Weekly Loser of Health Sector: Anavex Life Sciences Corp.'s (AVXL) - Is stories - Worst Weekly Loser of Health Sector: Anavex Life Sciences Corp.'s (AVXL)Is storiesAnavex Life Sciences Corp.'s (AVXL) witnessed a loss of -8.88% .The company's last traded volume of 1035799 shares. In the trailing 12 months period, return on assets ratio of the Company was -139.40% and return on equity ratio was -171.80%. The stock ...
05/14/16 01:10 PMEarnings Overview of the Stock: Anavex Life Sciences Corp. (NASDAQ:AVXL) - News Oracle - Motley FoolEarnings Overview of the Stock: Anavex Life Sciences Corp. (NASDAQ:AVXL)News OracleLast Trade: The Company fell -8.88% and finished at $4.00. The daily volume was measured at 1.04 million shares. The 52-week high of the share price is $14.84 and the 52-week low is $1.32. The company has a market cap of $156.77 million. Its latest ...Anavex Life Sciences Corp.'s (AVXL): Worst Weekly Loser of Health SectorIs storiesBiotech Volatile Stocks: Anavex Life Sciences Corp. (NASDAQ:AVXL), Oramed Pharmaceuticals Inc. (NASDAQ:ORMP ...KC RegisterTake a look at Analyst Tips: Inovio Pharmaceuticals, Inc. (NASDAQ:INO) , Anavex Life Sciences Corp. (NASDAQ:AVXL)Street UpdatesMotley Foolall 5 news articles »
05/13/16 01:03 PM5 Key Takeaways From Anavex Life Sciences' Second-Quarter Earnings -
05/13/16 12:57 PMAnavex Life Sciences Corp.'s (AVXL): Worst Weekly Loser of Health Sector - Is stories - Anavex Life Sciences Corp.'s (AVXL): Worst Weekly Loser of Health SectorIs storiesAnavex Life Sciences Corp.'s (AVXL) witnessed a loss of -8.88% .The company's last traded volume of 1035799 shares. In the trailing 12 months period, return on assets ratio of the Company was -139.40% and return on equity ratio was -171.80%. The stock ...Earnings Overview of the Stock: Anavex Life Sciences Corp. (NASDAQ:AVXL)News Oracleall 3 news articles »
05/12/16 01:02 PMYesterday Trading Recap: Catalent, Inc. (NYSE:CTLT) , Anavex Life Sciences Corp. (NASDAQ:AVXL) - Street Updates - Yesterday Trading Recap: Catalent, Inc. (NYSE:CTLT) , Anavex Life Sciences Corp. (NASDAQ:AVXL)Street UpdatesIn the past trading session, Anavex Life Sciences Corp. (NASDAQ:AVXL) highlighted downward shift of -2.23% or -0.10 points to $4.39. The company traded a volume of 344.49 thousand shares under average volume of 856.07 thousand shares. Trailing ...Earnings Trend per share for Investors: Anavex Life Sciences Corp. (NASDAQ:AVXL)News Oracleall 2 news articles »
05/12/16 01:02 PMAnavex Life Sciences Corp (AVXL) Receives “Buy” Rating from Maxim Group - Washington News Wire - Washington News WireAnavex Life Sciences Corp (AVXL) Receives “Buy” Rating from Maxim GroupWashington News WireAnavex Life Sciences Corp logo Anavex Life Sciences Corp (NASDAQ:AVXL)'s stock had its “buy” rating reaffirmed by stock analysts at Maxim Group in a research report issued on Wednesday, AnalystRatingsNetwork.com reports. They currently have a ...Anavex Life Sciences Corp (AVXL) Set to Announce Quarterly Earnings on FridayNewsWay 21Maxim Group Reiterates "Buy" Rating for Anavex Life Sciences Corp (AVXL)Web Breaking NewsAnavex Life Sciences Fiscal Q2 Loss Narrows (OTCMKTS:AVXL)Sonoran Weekly ReviewMoney Morning -GlobeNewswire (press release) -Analyst Ratingsall 7 news articles »
05/11/16 01:16 PMAnavex 2-73: Hints Of Success - Seeking Alpha - Anavex 2-73: Hints Of SuccessSeeking AlphaAccording to a recent news report out of Australia, Alzheimer's patients seemed to regain functions such as playing the piano, painting, and playing golf after taking Anavex 2-73 (NASDAQ:AVXL). Several doubts have been raised about the report: it was a ...
05/11/16 06:15 AMAnavex Life Sciences reports 2Q loss -
05/11/16 06:06 AM7:06 am Anavex reports Q1 results -
05/11/16 06:00 AMAnavex Reports Fiscal Second Quarter 2016 Financial Results - [GlobeNewswire] - NEW YORK, May 11, 2016-- Anavex Life Sciences Corp., a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases ...
05/11/16 05:15 AMANAVEX LIFE SCIENCES CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a -
05/10/16 01:35 PMEarnings Trendsof the Stock: Anavex Life Sciences Corp. (NASDAQ:AVXL) - News Oracle - Earnings Trendsof the Stock: Anavex Life Sciences Corp. (NASDAQ:AVXL)News OracleLast Trade: The Company fell -12.68% and finished at $4.20. The daily volume was measured at 1.34 million shares. The 52-week high of the share price is $14.84 and the 52-week low is $1.32. The company has a market cap of $171.70 million. Its latest ...
About Anavex Life Sciences Corp.

Anavex Life Sciences Corp. logoAnavex Life Sciences Corp., is a clinical-stage biopharmaceutical company engaged in the development of drug candidates. The Company's lead compounds include ANAVEX 2-73, ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil (Aricept), ANAVEX 19-144, ANAVEX 1-41, ANAVEX 7-1037, ANAVEX 3-71, ANAVEX 1079, ANAVEX 1519 and ANAVEX 1066 being developed to treat Alzheimer's disease and other central nervous system (CNS) diseases. The Company's SIGMACEPTOR Discovery Platform produced small molecule drug candidates with unique modes of action. Sigma receptors may be targets for therapeutics to combat many human diseases, including Alzheimer's disease. When bound by the appropriate ligands, sigma receptors influence the functioning of multiple biochemical signals that are involved in the pathogenesis (origin or development) of disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AVXL
  • CUSIP:
Key Metrics:
  • Previous Close: $6.11
  • 50 Day Moving Average: $4.40
  • 200 Day Moving Average: $4.84
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $203.90M
  • Current Quarter EPS Consensus Estimate: $-0.34 EPS
Additional Links:
Anavex Life Sciences Corp. (NASDAQ:AVXL) Chart for Friday, July, 1, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha